Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hpv: early-phase trial registry
15 of 25 indexed Hpv trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #652 of 28,707 conditions by registered trial count.
25 US clinical trials · 15 currently recruiting · #652 of 28,707 conditions by registered trial count
Hpv: 25 US clinical trials tracked, 15 recruiting.
Hpv is the subject of 25 registered US clinical trials on ClinicalTrials.gov, 15 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most active sponsor is National Cancer Institute (NCI), running 3 of these trials.
Enrollment posture brief
Registry condition hpv
OPEN 15 | RECR 60% | LATE 2 | EARLY 7 | RANK #652 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Abuse, Drug (60% recruiting · 5 trials)
Hpv lists 15 open slots (60% of 25 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hpv on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hpv is recruiting above its size-band peers.
15 of 25 indexed trials (60%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Hpv trials is spread across many organizations.
National Cancer Institute (NCI) accounts for 3 of 25 trials (12%). 18 distinct sponsors appear on at least one study for this condition label.
-
Typical Hpv enrolment sits around 180 participants.
Median target enrolment is 180 among the 25 trials that report a genuine target (sentinel values excluded). 7 of those (28%) plan for fewer than 100 participants.
-
Hpv research is mostly interventional.
21 interventional and 4 observational studies make up this index (84% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
25 total, page 1 of 1
Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination
University of Rochester
NCT06380114
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
University of Colorado, Denver
NCT04722822
HPV Self-Collection Program
University of Utah
NCT06674681
Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening
M.D. Anderson Cancer Center
NCT06109870
The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
National Institute of Allergy and Infectious Diseases (NIAID)
NCT01011712
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
Qurasense
NCT07281599
Playing Game to Learn About Children's Vaccine Project
Michigan State University
NCT05984849
A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer
Memorial Sloan Kettering Cancer Center
NCT05491512
PopSci CHW4CervixHealth
Thomas Jefferson University
NCT07336134
HPV Vaccine Reduced Dose
Emory University
NCT06799494
TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers
University of Chicago
NCT05108870
Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer
University of Chicago
NCT07065630
A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)
Memorial Sloan Kettering Cancer Center
NCT05307939
Treatment De-Escalation for Favorable Prognosis Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer Receiving Definitive Radiotherapy
Georgetown University
NCT06902623
BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients
M.D. Anderson Cancer Center
NCT05363709
Text and Talk: A Multi-level Intervention to Increase Provider HPV Vaccine Recommendation Effectiveness
University of Florida
NCT05006833
SELF-CERV Pivotal Study: SELF-Collection for CERVical Cancer Screening
Teal Health
NCT06120205
Advancing Cervical Cancer Screening Through the Emergency Department - IIS
University of Rochester
NCT06796738
Post-treatment Surveillance in HPV+ Oropharyngeal SCC
Dana-Farber Cancer Institute
NCT04965792
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
National Cancer Institute (NCI)
NCT04708470
Assessing Durable Antibody Response to HPV Vaccination
Emory University
NCT05031078
Low-Cost Molecular Cervical Cancer Screening Study
National Cancer Institute (NCI)
NCT01231945
Human Papillomavirus (HPV) Vaccination Acceptance by African-American Parents: Identifying Psychosocial Barriers
Syracuse University
NCT00680147
Pilots of Self-Collection for HPV DNA Detection
National Cancer Institute (NCI)
NCT00342511
Pilot HPV Vaccination in Chinese American Community
Temple University
NCT04505930
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 5 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Hpv records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hpv trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hpv page
25 registered trials, 15 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 15 Hpv trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Cancer Institute (NCI) sponsors the most Hpv trials on record, review their full trial history before evaluating a specific study. See National Cancer Institute (NCI)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hpv condition card totals 25 registered trials; most-linked intervention Carboplatin; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.